Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines
Clinical trial NCT00001210 · COMPLETED
Trial details
- NCT number
- NCT00001210
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 1986-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.